Literature DB >> 8738516

Possible induction of food allergy during mite immunotherapy.

R van Ree1, L Antonicelli, J H Akkerdaas, M S Garritani, R C Aalberse, F Bonifazi.   

Abstract

Sera of 17 patients receiving immunotherapy for house-dust mite allergy were tested for IgE antibodies against snail and shrimp. Serum samples were taken at the start of immunotherapy and 14-20 months later. While the average IgE response to mite, Der p 1, and Der p 2 did not alter significantly, the average response to snail showed a significant increase. This included two conversions from negative to strongly positive. These novel IgE antibodies against snail were shown to be cross-reactive with mite. Three patients had a positive RAST for shrimp. For one of them, a strong increase of IgE against shrimp (and snail) was observed. In 2/3 snail/shrimp-positive sera, IgE antibodies against the cross-reactive allergen tropomyosin from mite, snail, and shrimp were demonstrated. A clear IgE response to snail (> 10% binding in a snail RAST) was confirmed by a positive skin prick test (SPT) for 6/10 patients. The two patients with antitropomyosin IgE also had a positive SPT for shrimp, and demonstrated the oral allergy syndrome (OAS) after eating shrimp. The observations in this study indicate that house-dust mite immunotherapy is accompanied by the induction of IgE against foods, including tropomyosin-reactive IgE. Food allergy (OAS) was observed in patients that had IgE antibodies against this cross-reactive allergen. In conclusion, induction of IgE during mite immunotherapy might occasionally cause allergy to foods of invertebrate animal origin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738516

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  31 in total

Review 1.  Molecular biology of indoor allergens.

Authors:  A M Smith; A Pomes; M D Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-06       Impact factor: 8.667

Review 2.  Update on the diagnosis and treatment of shellfish allergy.

Authors:  Rosalía Ayuso
Journal:  Curr Allergy Asthma Rep       Date:  2011-08       Impact factor: 4.806

Review 3.  Bioinformatics approaches to classifying allergens and predicting cross-reactivity.

Authors:  Catherine H Schein; Ovidiu Ivanciuc; Werner Braun
Journal:  Immunol Allergy Clin North Am       Date:  2007-02       Impact factor: 3.479

Review 4.  Crossreactions in food allergy.

Authors:  E A Pastorello; C Incorvaia; V Pravettoni; C Ortolani
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 5.  The relevance of crossreactivity in pediatric allergy.

Authors:  C Y Pascual; J F Crespo; M Martin-Esteban
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

6.  Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy.

Authors:  Vijaya B Joshi; Andrea Adamcakova-Dodd; Xuefang Jing; Amaraporn Wongrakpanich; Katherine N Gibson-Corley; Peter S Thorne; Aliasger K Salem
Journal:  AAPS J       Date:  2014-07-01       Impact factor: 4.009

Review 7.  [Molecular-allergological aspects of allergen-specific immunotherapy].

Authors:  Uta Jappe
Journal:  Hautarzt       Date:  2017-04       Impact factor: 0.751

Review 8.  Mite immunotherapy.

Authors:  Enrique Fernández-Caldas; Victor Iraola; Manuel Boquete; Antonio Nieto; Miguel Casanovas
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

9.  Allergenic characterization of tropomyosin from the dusky brown cockroach, Periplaneta fuliginosa.

Authors:  Kyoung Yong Jeong; Heeyu Hwang; Jongweon Lee; In-Yong Lee; Dong Soo Kim; Chein-Soo Hong; Han-Il Ree; Tai-Soon Yong
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

10.  Lack of neo-sensitization to Pen a 1 in patients treated with mite sublingual immunotherapy.

Authors:  Renato E Rossi; Giorgio Monasterolo; Cristoforo Incorvaia; Philippe Moingeon; Franco Frati; Giovanni Passalacqua; Lucilla Rossi; Giorgio W Canonica
Journal:  Clin Mol Allergy       Date:  2010-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.